Literature DB >> 33719602

N-Acetylcysteine Interference with a Glucose Dehydrogenase Linked Glucose Meter.

Martha E Lyon1, Andrew W Lyon1.   

Abstract

BACKGROUND: Our objective was to determine the effect of therapeutic concentrations of N-acetylcysteine, following intravenous infusion, on the measurement of blood glucose using a Roche Diagnostics glucose dehydrogenase-linked glucose meter compared to hospital laboratory methods.
METHODS: N-acetylcysteine was added to aliquots of blood, with glucose promptly measured by the glucose meter, blood gas analyzer (glucose oxidase comparative method) and following centrifugation, plasma glucose measured with a hexokinase spectrophotometric comparative method. Glucose results were evaluated with linear regression and Bland Altman plots.
RESULTS: In the presence of NAC, at concentrations greater than 5 mg/dL (0.31 mmol/L), positively biased glucose meter results were compared to the clinical laboratory results. Multivariate linear regression revealed that NAC-mediated meter results are influenced by NAC and glucose concentrations.
CONCLUSIONS: The addition of therapeutic concentrations of NAC to blood produces statistically significant positive biases when measured with the glucose dehydrogenase linked glucose meter device.

Entities:  

Keywords:  Mucomyst®; accuracy; acetylcysteine; bias; glucose meter

Mesh:

Substances:

Year:  2021        PMID: 33719602      PMCID: PMC9445331          DOI: 10.1177/1932296821999416

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  12 in total

1.  Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine.

Authors:  B Olsson; M Johansson; J Gabrielsson; P Bolme
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  The danger of using inappropriate point-of-care glucose meters in patients on icodextrin dialysis.

Authors:  N J Perera; P M Stewart; P F Williams; E L Chua; D K Yue; S M Twigg
Journal:  Diabet Med       Date:  2011-10       Impact factor: 4.359

3.  Estimates of total analytical error in consumer and hospital glucose meters contributed by hematocrit, maltose, and ascorbate.

Authors:  Martha E Lyon; Jeffrey A DuBois; Gordon H Fick; Andrew W Lyon
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

4.  An assessment of the variation in the concentration of acetylcysteine in infusions for the treatment of paracetamol overdose.

Authors:  George P Bailey; David M Wood; John R H Archer; Edmund Rab; Robert J Flanagan; Paul I Dargan
Journal:  Br J Clin Pharmacol       Date:  2016-09-29       Impact factor: 4.335

5.  Electrochemical detection of thiols with a coenzyme pyrroloquinoline quinone modified electrode.

Authors:  T Inoue; J R Kirchhoff
Journal:  Anal Chem       Date:  2000-12-01       Impact factor: 6.986

6.  The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage.

Authors:  L F Prescott; J W Donovan; D R Jarvie; A T Proudfoot
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 7.  N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility.

Authors:  Seetal Dodd; Olivia Dean; David L Copolov; Gin S Malhi; Michael Berk
Journal:  Expert Opin Biol Ther       Date:  2008-12       Impact factor: 4.388

Review 8.  Interferences and Limitations in Blood Glucose Self-Testing: An Overview of the Current Knowledge.

Authors:  Michael Erbach; Guido Freckmann; Rolf Hinzmann; Bernhard Kulzer; Ralph Ziegler; Lutz Heinemann; Oliver Schnell
Journal:  J Diabetes Sci Technol       Date:  2016-08-22

9.  N-acetylcysteine protects against star fruit-induced acute kidney injury.

Authors:  Maria Heloisa Massola Shimizu; Pedro Henrique França Gois; Rildo Aparecido Volpini; Daniele Canale; Weverton Machado Luchi; Leila Froeder; Ita Pfeferman Heilberg; Antonio Carlos Seguro
Journal:  Ren Fail       Date:  2016-11-15       Impact factor: 2.606

10.  Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study.

Authors:  Alberto Papi; Andrea F D Di Stefano; Milko Radicioni
Journal:  Adv Ther       Date:  2020-11-04       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.